Patents by Inventor Dong Rack Choi

Dong Rack Choi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Arylsulfonylimidazolone derivatives as an antitumor agent
    Patent number: 5932742
    Abstract: The present invention relates to a novel arylsulfonylimidazolone derivative represented by the following formula (I) which shows a superior antineoplastic activity in contrast to the known sulfonylurea antitumor agents as well as little side effect: ##STR1## and its pharmaceutically acceptable salt and stereoisomer, in which - -, R.sub.1, and R.sub.2 are as defined in the specification.
    Type: Grant
    Filed: December 16, 1998
    Date of Patent: August 3, 1999
    Assignee: Dong Wha Pharm. Ind. Co., Ltd.
    Inventors: Sung June Yoon, Yong Ho Chung, Moon Sun Lee, Dong Rack Choi, Jung A Lee, Hee Soon Lee, Hae Ran Yun, Dug Keun Lee, Eun Yi Moon, Hyun Sook Hwang, Chung Ha Choi, Sang Hun Jung
  • Arylsulfonylimidazolone derivatives as an antitumor agent
    Patent number: 5929103
    Abstract: The present invention relates to a novel arylsulfonylimidazolone derivative represented by the following formula (I) which shows a superior antineoplastic activity in contrast to the known sulfonylurea antitumor agents as well as little side effect: ##STR1## and its pharmaceutically acceptable salt and stereoisomer, in which ----, R.sub.1, and R.sub.2 are as defined in the specification.
    Type: Grant
    Filed: August 21, 1997
    Date of Patent: July 27, 1999
    Assignee: Dong Wha Pharm. Ind. Co., Ltd.
    Inventors: Sung June Yoon, Yong Ho Chung, Moon Sun Lee, Dong Rack Choi, Jung A Lee, Hee Soon Lee, Hae Ran Yun, Dug Keun Lee, Eun Yi Moon, Hyun Sook Hwang, Chung Ha Choi, Sang Hun Jung
  • Quinolone carboxylic acid derivatives
    Patent number: 5496947
    Abstract: The present invention relates to the novel quinolone carboxylic acid derivatives of the following formula (I) and their pharmaceutically acceptable salts and their hydrates. ##STR1## wherein X is a hydrocarbon, fluorocarbon or nitrogen atom,Y is a hydrogen or methyl group,R.sup.1 is a hydrogen or alkyl group having 1 to 5 carbon atom,R.sup.2 is ##STR2## wherein A and B is a fluorocarbon or nitrogen atom, provided that, if A.dbd.CF, B.dbd.N and if A.dbd.N, B.dbd.CF) andR.sup.3 is ##STR3## (wherein R.sup.4 is an amino group which makes a racemate or (S)-enantiomer) or ##STR4## (wherein R.sup.5, R.sup.6 and R.sup.7 are respectively hydrogen or alkyl group having 1 to 3 carbon atom.).The compounds according to the present invention are used as antibacterial agents.
    Type: Grant
    Filed: February 8, 1994
    Date of Patent: March 5, 1996
    Assignee: Dong Wha Pharmaceutical Industrial Co., Ltd.
    Inventors: Sung-June Yoon, Young-Ho Chung, Chi-Woo Lee, Yoon-Seok Oh, Dong-Rack Choi, Nam-Doo Kim